The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-in-field small molecule inhibitors targeting BRN2 as a therapeutic strategy for small cell prostate cancer.
 
Daksh L. Thaper
Patents, Royalties, Other Intellectual Property - United Biosource Corporation
 
Ravi Munuganti
Patents, Royalties, Other Intellectual Property - United Biosource Corporation
 
Shaghayegh Nouruzi
No Relationships to Disclose
 
Sahil Kumar
No Relationships to Disclose
 
Soojin Kim
No Relationships to Disclose
 
Sepideh Vahid
Research Funding - United Biosource Corporation
 
Olena Sivak
No Relationships to Disclose
 
Adeleke Aguda
No Relationships to Disclose
 
Loredana Puca
No Relationships to Disclose
 
Himisha Beltran
Consulting or Advisory Role - Abbvie; Genzyme; GlaxoSmithKline; Janssen Oncology
Research Funding - Abbvie/Stemcentrx (Inst); Janssen (Inst); Lilly (Inst)
 
Amina Zoubeidi
Patents, Royalties, Other Intellectual Property - United Biosource Corporation